9,525 results match your criteria Catheterization and Cardiovascular Interventions[Journal]


Revascularization for multivessel disease: Getting closer, but….

Authors:
Samuel M Butman

Catheter Cardiovasc Interv 2020 Jul;96(1):52

Verde Valley Medical Center, Cottonwood, Arizona, USA.

In a registry, it is all about any differences. PCI and CABG for multivessel disease are comparable with regard to risk of death/MI/stroke, but PCI has a significantly higher risk of return to Cath Lab for PCI or even CABG in follow-up. Read More

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1002/ccd.29087DOI Listing

Can percutaneous coronary interventions be performed safely in leukemia patients?

Catheter Cardiovasc Interv 2020 Jul;96(1):64-65

Brookwood Baptist Health, Birmingham, Alabama.

Patients with leukemia are often denied percutaneous coronary intervention (PCI), and those who do undergo PCI are older and sicker. There is a minor increase in vascular complications and no increase in retroperitoneal bleeds, suggesting transfusions may be given for reasons unrelated to the PCI. Since cardiac complications are not increased in leukemia patients, the increased mortality observed in after PCI in acute leukemia may be related more to underlying malignancy. Read More

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1002/ccd.29076DOI Listing

Belt and suspenders: Why it pays to protect and cover during carotid stenting.

Catheter Cardiovasc Interv 2020 Jul;96(1):128

University of Arizona College of Medicine, Phoenix, Arizona, USA.

Carotid stenting results show equivalence to carotid endarterectomy. Most patients undergoing carotid intervention are asymptomatic. Using embolic protection with a covered mesh stent shows promise in this first large multicenter study. Read More

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1002/ccd.29083DOI Listing

Assessing atherothrombotic burden with optical coherence tomography analysis may facilitate post-PCI prognostication and antiplatelet therapy.

Catheter Cardiovasc Interv 2020 Jul;96(1):98-99

Department of Cardiology, Texas Heart Institute, Houston, Texas, USA.

Atherothrombotic burden (ATB) correlates with myocardial blush grade (MBG), a known predictor of mortality and outcome after ST-elevation myocardial infarction. Quantitative or semiquantitative analysis of ATB with optical coherence tomography may assist interventional cardiologists in post-PCI prognostication and, perhaps, in rendering more aggressive antiplatelet therapy. Future studies comparing treatment strategies for post-PCI patients with elevated ATB or depressed MBG may identify best practices after acute coronary syndromes. Read More

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1002/ccd.29088DOI Listing

Stitching your way to venous hemostasis.

Authors:
Zoltan G Turi

Catheter Cardiovasc Interv 2020 Jul;96(1):187-188

From the Division of Cardiology, Cooper University Hospital, Cooper Medical School at Rowan University, Camden, New Jersey, USA.

Venous compression using a purse string suture is a potential alternative to device suture of the venotomy or to the more extensively described Figure of 8 closure technique. The technique is likely to prove cost effective although the optimal methodology and overall risk remain to be determined. A general comment regarding the common femoral vein: it is a fragile structure. Read More

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1002/ccd.29077DOI Listing

Morphine in primary percutaneous coronary intervention-No pain, questionable gain.

Catheter Cardiovasc Interv 2020 Jul;96(1):89-90

Division of Cardiology and Cardiac Catheterization Laboratory, Tufts Medical Center, Boston, Massachusetts, USA.

The clinical impact of concurrently administered morphine and P2Y12 inhibitors in primary percutaneous coronary intervention (PCI) is not well understood. Large, randomized clinical trials are required to assess clinical outcomes with concurrent morphine and P2Y12 inhibitor use in ST-segment elevation myocardial infarction patients undergoing PCI. Based on the currently available pharmacologic data, cautious use of morphine in primary PCI would seem prudent. Read More

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1002/ccd.29091DOI Listing

Women with chronic kidney disease undergoing transcatheter aortic valve replacement: Caveat emptor.

Catheter Cardiovasc Interv 2020 Jul;96(1):208-209

Division of Cardiovascular Medicine, Department of Medicine, State University of New York at Stony Brook, Stony Brook, New York, USA.

Over 60% of women presenting for transcatheter aortic valve replacement (TAVR) have coexisting chronic kidney disease (CKD). In women undergoing TAVR, CKD was associated with significantly higher rates of adverse events, including a twofold higher rate of risk-adjusted mortality at 1 year. This study is an important step forward in our understanding of risk stratification in women with CKD undergoing TAVR and suggests that measures to optimize outcomes warrant further investigation in this high-risk group of patients. Read More

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1002/ccd.29080DOI Listing

Intervention in coronary bifurcation lesions: Staying on top of the proximal optimization technique (POT).

Catheter Cardiovasc Interv 2020 Jul;96(1):40-41

Department of Cardiovascular Sciences, Fortis Escorts Heart Institute, New Delhi, India.

Proximal optimization technique (POT) restores the stent to the fractal geometry of coronary bifurcations and is the final step when using two-stent strategy. Optimal positioning of balloon during final POT is vital to achieve best results without side branch compromise. In vitro studies provide valuable insights to define procedural strategies and help achieve best outcomes for coronary bifurcation lesions. Read More

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1002/ccd.29078DOI Listing

State-of-the-art percutaneous coronary interventions applied to the treatment of bifurcation lesions: Are we there yet?

Catheter Cardiovasc Interv 2020 Jul;96(1):18-19

Department of Medicine, University of Washington School of Medicine, Seattle, Washington, USA.

Treatment of bifurcation lesions has advanced with the development of second-generation drug-eluting stents and state-of-the-art percutaneous coronary interventions techniques. This subanalysis of SYNTAX II demonstrates similar major adverse cardiac or cerebrovascular events in patients with bifurcation and nonbifurcation lesions, with a trend toward higher target lesion failure in the bifurcation cohort. The results, while compelling, require larger studies with longer follow-up, stratified by bifurcation strategy. Read More

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1002/ccd.29085DOI Listing

Limb dysfunction after transradial access: A search for an understanding.

Authors:
Ian C Gilchrist

Catheter Cardiovasc Interv 2020 Jul;96(1):74-75

College of Medicine, Heart & Vascular Institute, MS Hershey Medical Center, Penn State University, Hershey, Pennsylvania, USA.

Limb dysfunction is common after radial access although many show dysfunction at baseline. Thrombosis may be present in the radial artery but is not necessary to manifest limb dysfunction. The role of periarterial nerve damage to this syndrome remains uncertain. Read More

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1002/ccd.29092DOI Listing

True caring is protecting who is at your side.

Catheter Cardiovasc Interv 2020 Jul;96(1):29-30

Cardiology Department, Azienda Ospedaliera Ordine Mauriziano di Torino, Torino, Italy.

The modified jailed balloon technique (MJBT) is a safe and effective tool for preserving immediate and long-term side branch (SB) patency when treating true bifurcation lesions. This technique could be routinely implemented, or selectively chosen when the risk of SB occlusion is high and a two-stent technique is not desirable. A randomized study comparing provisional stenting with the MJBT versus systematic two-stent strategy for the treatment of true bifurcation lesions is warranted. Read More

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1002/ccd.29081DOI Listing

Transcatheter versus surgical aortic valve replacement in the digital era: Meta-analysis based on the reconstruction of time-to-event individual patient data.

Catheter Cardiovasc Interv 2020 Jul;96(1):167-168

Department of Cardiac-Vascular-Thoracic Sciences, University of Padova, Padova, Italy.

Clinical benefits of transcatheter aortic valve replacement (TAVR) over surgery emerge soon after intervention and show durable, consistent trends within 1 year. TAVR by transfemoral access is associated with improved outcomes compared with TAVR by transthoracic access. Reconstructing time-to-event individual patient data is advantageous and allows higher flexibility in terms of meta-analysis design and modeling of data. Read More

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1002/ccd.29079DOI Listing

Peripheral vascular disease in women: Are we analyzing the costs correctly?

Catheter Cardiovasc Interv 2020 Jul;96(1):143-144

Lankenau Medical Center, Main Line Health System, Wynnewood, Pennsylvania, USA.

Women treated with a peripheral vascular intervention, on average, have more comorbidities and cost more per hospital admission than women treated with a percutaneous coronary intervention. The impact of critical limb ischemia on these results is likely significant, but not available in these data. Physicians need to be more aware of the differences in the risks and manifestations of cardiovascular disease in women. Read More

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1002/ccd.29086DOI Listing

Appraisal of urgent transcatheter aortic valve replacement.

Authors:
Ran Kornowski

Catheter Cardiovasc Interv 2020 Jul;96(1):196-197

Department of Cardiology, Rabin Medical Center, The Faculty of Medicine, Tel Aviv University, Petach Tikva, Israel.

Urgent transcatheter aortic valve replacement (TAVR) is needed in unstable patients with severe aortic stenosis and acute decompensated heart failure who are refractory to initial medical management. The outcome of urgent TAVR is worse and heavily influenced by the severity of the clinical status prior to intervention. Careful patient evaluation, procedural planning, and postoperative management should be optimized to improve the clinical results. Read More

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1002/ccd.29075DOI Listing

Ticagrelor monotherapy in patients undergoing percutaneous coronary intervention for bifurcation lesions.

Catheter Cardiovasc Interv 2020 Jul;96(1):112-113

Division of Cardiology, Department of Advanced Biomedical Sciences, University of Naples Federico II, Naples, Italy.

Ticagrelor monotherapy after a short course of aspirin is emerging as the predominant aspirin-free strategy among patients undergoing percutaneous coronary intervention. In patients included in the GLOBAL-LEADERS trial, the treatment effect of the experimental (dual antiplatelet therapy with aspirin and ticagrelor for 1 month followed by ticagrelor monotherapy) versus control strategy remained consistent irrespective of the presence or absence of coronary bifurcation. Ticagrelor monotherapy represents a safe and effective antiplatelet strategy for the treatment of patients who undergo percutaneous coronary intervention of bifurcation lesions. Read More

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1002/ccd.29082DOI Listing

One-year outcomes of supersaturated oxygen therapy in acute anterior myocardial infarction: The IC-HOT study.

Catheter Cardiovasc Interv 2020 Jul 10. Epub 2020 Jul 10.

Clinical Trials Center, Cardiovascular Research Foundation, New York.

Background: Supersaturated oxygen (SSO ) has recently been approved by the U.S. Food and Drug Administration for administration after primary percutaneous coronary intervention (pPCI) in patients with anterior ST-segment elevation myocardial infarction (STEMI) based on its demonstration of infarct size reduction in the IC-HOT study. Read More

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1002/ccd.29090DOI Listing

Interaction between severe chronic kidney disease and acute kidney injury in predicting mortality after transcatheter aortic valve implantation: Insights from the Italian Clinical Service Project.

Catheter Cardiovasc Interv 2020 Jul 9. Epub 2020 Jul 9.

Cardiothoracic Department, ASST Spedali Civili di Brescia, Brescia, Italy.

Aims: We aim at exploring whether severe chronic kidney disease (CKD) may modify the impact of acute kidney injury (AKI) post-transcatheter aortic valve implantation (TAVI) on early, mid, and long-term mortality.

Methods And Results: The analysis included 2,733 TAVI patients from the Italian Clinical Service Project. The population was stratified in four groups according to the presence of baseline severe CKD and postprocedural AKI. Read More

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1002/ccd.28927DOI Listing

The role of rivaroxaban for patients with atherosclerotic vascular disease in the modern era.

Catheter Cardiovasc Interv 2020 Jul 8. Epub 2020 Jul 8.

Division of Cardiology, Knight Cardiovascular Institute, Oregon Health and Science University, Portland, Oregon, USA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1002/ccd.29089DOI Listing

Bioprosthetic valve oversizing is associated with increased risk of valve thrombosis following TAVR.

Catheter Cardiovasc Interv 2020 Jul 6. Epub 2020 Jul 6.

Division of Cardiovascular Medicine, Knight Cardiovascular Institute, Oregon Health & Science University, Portland, Oregon, USA.

Background: Hypoattenuating leaflet thickening (HALT), the radiographic manifestation of transcatheter heart valve thrombosis, is commonly identified following transcatheter aortic valve replacement (TAVR) and associated with increased risk of stroke and structural valve deterioration. While anticoagulation effectively resolves HALT, routine use remains controversial. We aimed to identify hemodynamic, anatomic, and comorbid predictors of HALT. Read More

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1002/ccd.29104DOI Listing

Transcatheter aortic valve implantation (TAVI) in cardiogenic shock: TAVI-shock registry results.

Catheter Cardiovasc Interv 2020 Jul 6. Epub 2020 Jul 6.

Interventional Cardiology Unit, Department of Cardiac, Thoracic and Vascular Sciences and Public Health, University of Padua, Padua, Italy.

Objectives: Aim of this study is to evaluate safety, feasibility, and mid-term outcome of transcatheter aortic valve implantation (TAVI) in cardiogenic shock (CS).

Background: Balloon aortic valvuloplasty in patients with severe aortic valve stenosis (SAS) complicated by CS is indicated but associated with a grim prognosis. TAVI might be a more reasonable treatment option in this setting but data are scant. Read More

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1002/ccd.29112DOI Listing

Three-year outcome with drug-coated balloon percutaneous coronary intervention in coronary Takayasu arteritis: A case review.

Catheter Cardiovasc Interv 2020 Jul 4. Epub 2020 Jul 4.

Cardiology Clinical Academic Group, St George's Hospital, London, UK.

We describe the first long-term follow-up of a young patient with active Takayasu arteritis who presented with an acute coronary syndrome, treated endovascularly with percutaneous coronary intervention without stenting. A drug-coated balloon was used with high-resolution coronary imaging guidance in the form of optical coherence tomography on a critical ostial left anterior descending coronary artery lesion. A repeat procedure was undertaken after 4 months confirming a durable coronary angioplasty result and the patient remained symptom-free beyond 3 years. Read More

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1002/ccd.29099DOI Listing

Spontaneous thrombosis of a transcatheter aortic valve replacement-induced aortic root pseudoaneurysm.

Catheter Cardiovasc Interv 2020 Jul 4. Epub 2020 Jul 4.

The Heart Center - Rigshospitalet, Copenhagen University Hospital, Copenhagen, Denmark.

Aortic annulus rupture or aortic root perforation is a rare complication of transcatheter aortic valve replacement (TAVR), requiring emergent cardiac surgery and carrying a high intraoperative mortality. Few cases can be managed conservatively, provided a strict clinical follow-up. This study describes the case of a 78-year-old patient with a degenerated bicuspid aortic valve stenosis who presented with a late aortic root perforation following TAVR, which was successfully managed applying a "watchful waiting" approach. Read More

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1002/ccd.29108DOI Listing

Left main bifurcation lesions: Medina reclassification revisited-as easy as ABC.

Catheter Cardiovasc Interv 2020 Jul 4. Epub 2020 Jul 4.

Keele Cardiovascular Research Group, Keele University, Stoke-on-Trent, UK.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1002/ccd.29121DOI Listing
July 2020
2.107 Impact Factor

Residual functional SYNTAX score by quantitative flow ratio and improvement of exercise capacity after revascularization.

Catheter Cardiovasc Interv 2020 Jul 3. Epub 2020 Jul 3.

Division of Cardiology, Department of Internal Medicine, Heart Vascular Stroke Institute, Samsung Medical Center, Sungkyunkwan University School of Medicine, Seoul, Republic of Korea.

Objectives: This study aimed to evaluate the association between improvement in exercise capacity and functional completeness of revascularization, determined by residual functional SYNTAX score (rFSS), which is the sum of residual SYNTAX score of the vessels with post- percutaneous coronary intervention (PCI) quantitative flow ratio (QFR) ≤0.80.

Background: In patients with stable ischemic heart disease (SIHD), the efficacy of PCI in improving exercise capacity has been under debate and the differential effect of PCI for exercise capacity, according to functional completeness of revascularization, has not been evaluated. Read More

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1002/ccd.29118DOI Listing

Chronic total occlusion revascularization for ventricular arrhythmias?-Still more work to be done.

Catheter Cardiovasc Interv 2020 Jul 3. Epub 2020 Jul 3.

Department of Medicine, Division of Cardiology, Landsman Heart & Vascular Center, Lahey Hospital & Medical Center, Burlington, Massachusetts, USA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1002/ccd.29133DOI Listing

Implication of Impella-supported percutaneous coronary intervention.

Authors:
Teruhiko Imamura

Catheter Cardiovasc Interv 2020 Jul 3. Epub 2020 Jul 3.

Second Department of Internal Medicine, University of Toyama, Toyama, Japan.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1002/ccd.29122DOI Listing

Letter to the Editor concerning the article: "Comparison of drug eluting versus bare metal stents".

Catheter Cardiovasc Interv 2020 Jul 2. Epub 2020 Jul 2.

Department Pediatric Cardiology, CHU-Saint Justine, Université de Montréal, Montreal, QC, Canada.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1002/ccd.29135DOI Listing

Feasibility and safety of a fully percutaneous transcatheter aortic valve replacement program.

Catheter Cardiovasc Interv 2020 Jul 1. Epub 2020 Jul 1.

The Heart Center, Rigshospitalet, Copenhagen University Hospital, Copenhagen, Denmark.

Objectives: This study aimed to assess the feasibility and safety of conducting an entire transcatheter aortic valve replacement (TAVR) program by using percutaneous techniques only.

Background: Surgically assisted transthoracic TAVR has been reported to be associated with more complications and longer hospital stays.

Methods: During 2019, all TAVR at a single center were performed by standard transfemoral (TF), intravascular lithotripsy-assisted TF, transaxillary (TAx), or transcaval approach using percutaneous techniques only. Read More

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1002/ccd.29117DOI Listing

Improving cardiology fellow education of right heart catheterization using a simulation based curriculum.

Catheter Cardiovasc Interv 2020 Jun 30. Epub 2020 Jun 30.

Feinberg School of Medicine, Northwestern University, Chicago, Illinois, USA.

Background: Medical procedures are traditionally taught informally at patients' bedside through observation and practice using the adage "see one, do one, teach one." This lack of formalized training can cause trainees to be unprepared to perform procedures independently. Simulation based education (SBE) increases competence, reduces complications, and decreases costs. Read More

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1002/ccd.29128DOI Listing

Single-access during Impella hemodynamic support utilizing the Railway system.

Catheter Cardiovasc Interv 2020 Jun 30. Epub 2020 Jun 30.

Allina Health, Metropolitan Heart and Vascular Institute, Minneapolis, Minnesota, USA.

A single-access technique during mechanical circulatory support (MCS) and percutaneous coronary intervention (PCI) has been described for those patients where an additional arterial access site is not available or desired. This technique utilizes the Impella (Abiomed, Danvers, MA) 14 French (F) sheath as a single-access point, with a 7 F sheath through the 14 F sheath hemostatic valve next to the Impella catheter (Abiomed). However, this technique is limited to a 7 F sheath or smaller and can be difficult requiring multiple attempts and limit guide catheter manipulation. Read More

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1002/ccd.29096DOI Listing

SAPIEN S3 valve deployment in the pulmonary position using the gore DrySeal sheath to protect the tricuspid valve.

Catheter Cardiovasc Interv 2020 Jun 30. Epub 2020 Jun 30.

Department of Pediatrics, Charles E. Mullins Cardiac Catheterization Laboratories, Texas Children's Hospital, and Lillie Frank Abercrombie Section of Cardiology, Baylor College of Medicine, Houston, Texas, USA.

Background: Tricuspid valve injury can occur during implantation of a SAPIEN valve in the pulmonary position. We describe our experience using a long Gore DrySeal (GDS) sheath to protect the tricuspid valve during advancement of the Commander delivery system.

Methods: Retrospective single center review of all patients who underwent placement of a SAPIEN valve in the right ventricular outflow tract between January 2016 and April 2020. Read More

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1002/ccd.29120DOI Listing

CT-Angiography to predict outcome after indirect mitral annuloplasty in patients with functional mitral regurgitation.

Catheter Cardiovasc Interv 2020 Jun 30. Epub 2020 Jun 30.

Department of Cardiology, Rheinlandklinikum Neuss, Neuss, Germany.

Objectives: Coronary sinus (CS) based mitral annuloplasty using the Carillon device is effective in reducing functional mitral valve regurgitation (FMR). However, this positive effect might be dependent on the relation between CS and the mitral annulus.

Background: Computed tomography (CT) assessment prior to mitral valve interventions is an emerging technique to optimize patient selection. Read More

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1002/ccd.29107DOI Listing

Equipment utilization in chronic total occlusion percutaneous coronary interventions: Insights from the PROGRESS-CTO registry.

Catheter Cardiovasc Interv 2020 Jun 29. Epub 2020 Jun 29.

Columbia University, New York, USA.

Background: We examined guidewire and microcatheter utilization during chronic total occlusion (CTO) percutaneous coronary intervention (PCI).

Methods: We examined device utilization in 2,968 CTO PCIs performed in 2,936 patients at 19 US and two international center between January 2016 and January 2019.

Results: The median number of antegrade guidewires used per case declined (5 in 2016 vs 3 in 2019) and was higher in higher complexity lesions (2 in J-CTO 0 vs. Read More

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1002/ccd.29106DOI Listing

Additive prognostic value of carbohydrate antigen-125 over frailty in patients undergoing transcatheter aortic valve replacement.

Catheter Cardiovasc Interv 2020 Jun 28. Epub 2020 Jun 28.

Department of Interventional Cardiology, Hospital Italiano de Buenos Aires, Buenos Aires, Argentina.

Background: To evaluate the additive prognostic value of myocardial, inflammatory, and renal biomarkers according to frailty status in patients undergoing transcatheter aortic valve replacement (TAVR) for aortic stenosis (AS).

Methods: A total of 111 subjects who underwent TAVR at Hospital Italiano de Buenos Aires, Argentina between January 2016 and December 2018 were retrospectively reviewed. Plasma levels of N-terminal pro-B-type natriuretic peptide (NT-proBNP), high sensitivity troponin T (hs-cTnT), C-reactive protein (CRP), cystatin-c (Cys-C) and carbohydrate antigen-125 (CA-125) were assessed prior to TAVR. Read More

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1002/ccd.29067DOI Listing

Direct transpedal pressure measurement during transpedal below-the-knee interventions in critical limb ischemia.

Catheter Cardiovasc Interv 2020 Jun 29. Epub 2020 Jun 29.

Mount Sinai Beth Israel, New York, USA.

Aim: The aim of this study was to assess the feasibility of the distal pressure measurement during transpedal below-the-knee interventions in chronic limb-threatening ischemia (CLTI) and to assess the hemodynamic response after percutaneous transluminal angioplasty.

Methods: The clinical and angiographic data of 137 consecutive patients treated via transpedal access in CLTI (Rutherford 4-6) were evaluated. Distal pedal pressure (PP) at the end of the pedal sheath was measured and the pedal-to-aortic pressure index (PAPI) was also calculated before and after the intervention. Read More

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1002/ccd.29101DOI Listing

Impact of lesion preparation strategies on outcomes of left main PCI: The EXCEL trial.

Catheter Cardiovasc Interv 2020 Jun 27. Epub 2020 Jun 27.

Clinical Trials Center, Cardiovascular Research Foundation, New York, New York, USA.

Objectives: We examined outcomes according to lesion preparation strategy (LPS) in patients with left main coronary artery (LMCA) percutaneous coronary intervention (PCI) in the EXCEL trial.

Background: The optimal LPS for LMCA PCI is unclear.

Methods: We categorized LPS hierarchically (high to low) as: (a) rotational atherectomy (RA); (b) cutting or scoring balloon (CSB); (c) balloon angioplasty (BAL); and d) direct stenting (DIR). Read More

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1002/ccd.29116DOI Listing

Concept of fracturing a small-sized bioprothesis for further valve in valve implantation.

Catheter Cardiovasc Interv 2020 Jun 27. Epub 2020 Jun 27.

Pediatric Cardiology, German Heart Center, Germany.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1002/ccd.29126DOI Listing

Drug-Coated balloons vs drug-eluting stents for the treatment of small coronary artery disease: A meta-analysis of randomized trials.

Catheter Cardiovasc Interv 2020 Jun 27. Epub 2020 Jun 27.

Department of Biomedical Sciences, Humanitas University, Department of Cardiovascular Medicine, Humanitas Clinical and Research Center, IRCCS, Via Alessandro Manzoni, 56, Rozzano (Milan), 20089, Italy.

Objectives And Background: There is conflicting evidence about the effects of drug-coated balloons (DCB) compared with drug-eluting stents (DES) in patients with native small vessel coronary artery disease (CAD).

Methods: The PubMed, Embase, Cochrane Central Register of Controlled Trials, and ClinicalTrials.gov databases and main international conference proceedings were searched for randomized controlled trials (RCT) comparing DCB versus DES in patients with native small vessel CAD. Read More

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1002/ccd.29111DOI Listing

Optimizing complex, high-risk indicated percutaneous coronary interventions: The future of interventional cardiology.

Catheter Cardiovasc Interv 2020 Jun 27. Epub 2020 Jun 27.

Department of Interventional Cardiology, Heart, Vascular, and Thoracic Institute, Cleveland Clinic, Cleveland, Ohio, USA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1002/ccd.29127DOI Listing

Access site related vascular complications with third generation transcatheter heart valve systems.

Catheter Cardiovasc Interv 2020 Jun 26. Epub 2020 Jun 26.

Department of Cardiovascular Surgery, German Heart Center, TUM, INSURE (Institute for Translational Cardiac Surgery), Munich, Germany.

Objectives: This study examines the impact of anatomical and procedural factors on Valve Academic Research Consortium-2-defined vascular complications at the femoral access site in transcatheter aortic valve replacement (TAVR) with third generation transcatheter heart valve (THV)-systems.

Background: Randomized clinical trials reported on vascular complications with current THV-systems. However, clinical presentation and consequences of these events are not well studied. Read More

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1002/ccd.29095DOI Listing

Outcomes of urgent/emergent transcatheter mitral valve repair (MitraClip): A single center experience.

Catheter Cardiovasc Interv 2020 Jun 26. Epub 2020 Jun 26.

Division of Cardiology, Department of Medicine, University of Washington, Seattle, Washington, USA.

Objectives: To describe the outcomes of urgent/emergent transcatheter edge-to-edge mitral valve repair (TMVr) and compare the clinical, echocardiographic, and procedural characteristics of survivors and nonsurvivors.

Background: TMVr is a treatment strategy for select patients with severe primary or secondary mitral regurgitation. However, knowledge regarding outcomes for urgent/emergent TMVr is limited. Read More

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1002/ccd.29084DOI Listing

Prioritizing elective cardiovascular procedures during the COVID-19 pandemic: The cardiovascular medically necessary, time-sensitive procedure scorecard.

Catheter Cardiovasc Interv 2020 Jun 26. Epub 2020 Jun 26.

Division of Cardiology, Newark Beth Israel Medical Center, Newark, New Jersey, USA.

Background: Following the surge of the coronavirus disease 2019 (COVID-19) pandemic, government regulations, and recommendations from professional societies have conditioned the resumption of elective surgical and cardiovascular (CV) procedures on having strategies to prioritize cases because of concerns regarding the availability of sufficient resources and the risk of COVID-19 transmission.

Objectives: We evaluated the use of a scoring system for standardized triage of elective CV procedures.

Methods: We retrospectively reviewed records of patients scheduled for elective CV procedures that were prioritized ad hoc to be either performed or deferred when New Jersey state orders limited the performance of elective procedures due to the COVID-19 pandemic. Read More

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1002/ccd.29093DOI Listing

Association between surgical risk and 30-day stroke after transcatheter versus surgical aortic valve replacement: a systematic review and meta-analysis.

Catheter Cardiovasc Interv 2020 Jun 25. Epub 2020 Jun 25.

Department of Cardiac, Thoracic, Vascular Sciences and Public Health, University of Padua Medical School, Padua, Italy.

Background: Stroke is a feared complication of transcatheter aortic valve replacement (TAVR) and surgical aortic valve replacement (SAVR).

Objectives: With this meta-analysis we aimed to evaluate the incidence of 30-day stroke with TAVR and SAVR focusing on its possible correlation with surgical risk.

Methods: Major electronic databases were searched for studies published between January 2002 and October 2019 reporting the rates of 30-day stroke after TAVR and SAVR. Read More

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1002/ccd.29105DOI Listing

Robotic telestenting performance in transcontinental and regional pre-clinical models.

Catheter Cardiovasc Interv 2020 Jun 25. Epub 2020 Jun 25.

Corindus, A Siemens Healthineers Company, Waltham, Massachusetts.

Objectives: This study was conducted to evaluate the association of geographic distance with robotic telestenting performance by comparing performance measures in transcontinental and regional pre-clinical models of telestenting.

Background: Robotic telestenting, in which percutaneous coronary intervention (PCI) is performed on a remotely located patient, might improve PCI access, but has not been attempted over vast distances likely required to reach many underserved regions.

Methods: Telestenting performance was compared in regional (Boston to New York [206 miles]) and transcontinental (Boston to San Francisco [3,085 miles]) ex vivo models of telestenting, wherein a physician in Boston attempted robotic PCI on endovascular simulators in New York and San Francisco, respectively. Read More

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1002/ccd.29115DOI Listing

Unmasking psychological reasons of delay in acute coronary syndromes presentation during the COVID-19 pandemic.

Catheter Cardiovasc Interv 2020 Jun 25. Epub 2020 Jun 25.

C.A.S.T., A.O.U. "Policlinico-Vittorio Emanuele"-University of Catania, Catania, Italy.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1002/ccd.29103DOI Listing

Single stick access using a VA-ECMO arterial return cannula for coronary intervention in cardiogenic shock.

Catheter Cardiovasc Interv 2020 Jun 25. Epub 2020 Jun 25.

The CardioVascular Center, Tufts Medical Center, Boston, Massachusetts, USA.

Use of veno-arterial extracorporeal membrane oxygenation (VA-ECMO) is growing exponentially for cardiogenic shock and cardiac arrest, and many of these patients require percutaneous coronary intervention (PCI). In some cases, radial arterial access may not feasible among patients with peripheral vascular disease or if larger diameter guide catheters are required. Further, VA-ECMO is commonly used in combination with an intra-aortic balloon pump or Impella, thereby limiting vascular access options and increasing the risk of vascular complications including bleeding and limb ischemia. Read More

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1002/ccd.29073DOI Listing

European Bifurcation Club white paper on stenting techniques for patients with bifurcated coronary artery lesions.

Catheter Cardiovasc Interv 2020 Jun 24. Epub 2020 Jun 24.

Medical Faculty, Department of Cardiology, Clinical Center of Serbia, University of Belgrade, Belgrade, Serbia.

Background: Defining the optimal conduction of percutaneous-coronary-intervention (PCI) to treat bifurcation lesions has been the subject of many clinical studies showing that the applied stenting technique may influence clinical outcome. Accordingly, bifurcation stenting classifications and technical sequences should be standardized to allow proper reporting and comparison.

Methods: The European Bifurcation Club (EBC) is a multidisciplinary group dedicated to optimize the treatment of bifurcations and previously created a classification of bifurcation stenting techniques that is based on the first stent implantation site. Read More

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1002/ccd.29071DOI Listing

Current trends in utilization of fibrinolytic-based reperfusion strategies and bleeding outcomes in ST-elevation myocardial infarction.

Catheter Cardiovasc Interv 2020 Jun 23. Epub 2020 Jun 23.

Division of Cardiovascular Medicine, North Shore-Long Island Jewish Medical Centers, Northwell Health, and Assistant Professor, Zucker School of Medicine, New York, New York, USA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1002/ccd.29094DOI Listing

A single healthcare experience with Impella RP.

Catheter Cardiovasc Interv 2020 Jun 22. Epub 2020 Jun 22.

Division of Cardiology, Department of Medicine, Emory University School of Medicine, Atlanta, Georgia, USA.

Objectives: To understand the predictors of survival and indications for Impella RP in a single healthcare experience.

Background: The Impella RP can be used to temporarily support patients with right ventricular (RV) dysfunction after left ventricular assist device (LVAD) placement or myocardial infarction (MI). However, recent postmarket approval data have raised concerns of higher than expected mortality with this device. Read More

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1002/ccd.28986DOI Listing